Newcore Gold Ltd. (PCR.V) (CVE:PCR – Get Free Report) Director Barry Johnson Blayne acquired 50,000 shares of the company’s stock in a transaction on Tuesday, December 24th. The shares were purchased at an average cost of C$0.31 per share, for a total transaction of C$15,250.00.
Newcore Gold Ltd. (PCR.V) Stock Up 1.4 %
CVE:PCR opened at C$0.74 on Friday. The company has a market capitalization of C$59.16 million and a PE ratio of -185.00. Newcore Gold Ltd. has a 52-week low of C$0.14 and a 52-week high of C$0.86. The stock’s 50 day moving average price is C$0.74 and its 200 day moving average price is C$0.74.
Newcore Gold Ltd. (PCR.V) Company Profile
Further Reading
- Five stocks we like better than Newcore Gold Ltd. (PCR.V)
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Top 3 Investment Themes to Watch for in 2025
- Where to Find Earnings Call Transcripts
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- Bank Stocks – Best Bank Stocks to Invest In
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Newcore Gold Ltd. (PCR.V) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Newcore Gold Ltd. (PCR.V) and related companies with MarketBeat.com's FREE daily email newsletter.